These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Antibacterial effect of cefixime in the presence of the type of beta-lactamases produced by Enterobacteriaceae]. Philippon A; Jarlier V; Legrand P; Fournier G; Nicolas MH; Duval J Presse Med; 1989 Oct; 18(32):1560-6. PubMed ID: 2530532 [TBL] [Abstract][Full Text] [Related]
3. [Rapid detection of extended-spectrum beta-lactamases by flow cytometry method]. Duyan S; Kılıç A; Yılmaz S; Ardıç N Mikrobiyol Bul; 2015 Oct; 49(4):600-8. PubMed ID: 26649418 [TBL] [Abstract][Full Text] [Related]
4. Concomitant dissemination of three extended-spectrum beta-lactamases among different Enterobacteriaceae isolated in a French hospital. de Champs C; Sirot D; Chanal C; Poupart MC; Dumas MP; Sirot J J Antimicrob Chemother; 1991 Apr; 27(4):441-57. PubMed ID: 1856124 [TBL] [Abstract][Full Text] [Related]
5. [Activity of 9 beta-lactam antibiotics combined with clavulanic acid or sulbactam against the strains of broad-spectrum beta-lactamase (CTX-1) producing Enterobacteriaceae isolated at the Henri Mondor Hospital]. Legrand P; Soussy CJ; Orsoni A; Brickley X; Duval J Pathol Biol (Paris); 1988 May; 36(5):425-9. PubMed ID: 3043338 [TBL] [Abstract][Full Text] [Related]
6. Extended-spectrum beta-lactamases in enterobacteriaceae in Buenos Aires, Argentina, public hospitals. Quinteros M; Radice M; Gardella N; Rodriguez MM; Costa N; Korbenfeld D; Couto E; Gutkind G; Antimicrob Agents Chemother; 2003 Sep; 47(9):2864-7. PubMed ID: 12936986 [TBL] [Abstract][Full Text] [Related]
7. Distribution of extended-spectrum beta-lactamases in clinical isolates of Enterobacteriaceae in Vietnam. Cao V; Lambert T; Nhu DQ; Loan HK; Hoang NK; Arlet G; Courvalin P Antimicrob Agents Chemother; 2002 Dec; 46(12):3739-43. PubMed ID: 12435670 [TBL] [Abstract][Full Text] [Related]
8. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics]. Susić E Acta Med Croatica; 2004; 58(4):307-12. PubMed ID: 15700687 [TBL] [Abstract][Full Text] [Related]
9. Frequency and epidemiology of extended-spectrum β-lactamase-producing Enterobacteriaceae isolates susceptible to third-generation cephalosporins or to aztreonam. Bert F; Bialek-Davenet S; Leflon-Guibout V; Noussair L; Nicolas-Chanoine MH Med Mal Infect; 2014 Feb; 44(2):76-8. PubMed ID: 24525113 [TBL] [Abstract][Full Text] [Related]
10. Prevalence of extended spectrum beta-lactamases among Enterobacteriaceae: an Italian survey. Bonfiglio G; Perilli M; Stefani S; Amicosante G; Nicoletti G Int J Antimicrob Agents; 2002 Mar; 19(3):213-7. PubMed ID: 11932144 [TBL] [Abstract][Full Text] [Related]
11. NXL104 combinations versus Enterobacteriaceae with CTX-M extended-spectrum beta-lactamases and carbapenemases. Livermore DM; Mushtaq S; Warner M; Miossec C; Woodford N J Antimicrob Chemother; 2008 Nov; 62(5):1053-6. PubMed ID: 18689875 [TBL] [Abstract][Full Text] [Related]
12. Use of microdilution panels with and without beta-lactamase inhibitors as a phenotypic test for beta-lactamase production among Escherichia coli, Klebsiella spp., Enterobacter spp., Citrobacter freundii, and Serratia marcescens. Thomson KS; Sanders CC; Moland ES Antimicrob Agents Chemother; 1999 Jun; 43(6):1393-400. PubMed ID: 10348759 [TBL] [Abstract][Full Text] [Related]
13. Relationship between the distribution of cefepime minimum inhibitory concentrations and detection of extended-spectrum β-lactamase production among clinically important Enterobacteriaceae isolates obtained from patients in intensive care units in Taiwan: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2007. Jean SS; Lee WS; Bai KJ; Lam C; Hsu CW; Yu KW; Liao CH; Chang FY; Ko WC; Wu JJ; Chen YH; Chen YS; Liu JW; Lu MC; Liu CY; Chen RJ; Hsueh PR J Microbiol Immunol Infect; 2015 Feb; 48(1):85-91. PubMed ID: 23973410 [TBL] [Abstract][Full Text] [Related]
14. Laboratory identification, risk factors, and clinical outcomes of patients with bacteremia due to Escherichia coli and Klebsiella pneumoniae producing extended-spectrum and AmpC type β-lactamases. Tsui K; Wong SS; Lin LC; Tsai CR; Chen LC; Huang CH J Microbiol Immunol Infect; 2012 Jun; 45(3):193-9. PubMed ID: 22580086 [TBL] [Abstract][Full Text] [Related]
15. [In vitro activity of meropenem and seven other beta-lactam antibiotics against K.pneumoniae and enterobacteriaceae producing beta-lactamases with extended spectrum]. Cavallo JD; Fabre R; Crenn Y; Meyran M Pathol Biol (Paris); 1994 May; 42(5):365-8. PubMed ID: 7824297 [TBL] [Abstract][Full Text] [Related]
16. First report of the emergence of CTX-M-type extended-spectrum beta-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system. Lewis JS; Herrera M; Wickes B; Patterson JE; Jorgensen JH Antimicrob Agents Chemother; 2007 Nov; 51(11):4015-21. PubMed ID: 17724160 [TBL] [Abstract][Full Text] [Related]
17. [Comparative activities of 15 beta-lactam antibiotics against 590 strains of Klebsiella pneumoniae according to the production of beta-lactamase]. Bercion R; Meyran M; Labia R; Thabaut A Pathol Biol (Paris); 1991 May; 39(5):353-60. PubMed ID: 1881669 [TBL] [Abstract][Full Text] [Related]
18. Broth microdilution method to detect extended-spectrum beta-lactamases and AmpC beta-lactamases in enterobacteriaceae isolates by use of clavulanic acid and boronic acid as inhibitors. Jeong SH; Song W; Kim JS; Kim HS; Lee KM J Clin Microbiol; 2009 Nov; 47(11):3409-12. PubMed ID: 19710269 [TBL] [Abstract][Full Text] [Related]
19. Variety of TEM-, SHV-, and CTX-M-type beta-lactamases present in recent clinical isolates of Escherichia coli, Klebsiella pneumoniae, and Enterobacter cloacae from Taiwan. Ma L; Chang FY; Fung CP; Chen TL; Lin JC; Lu PL; Huang LY; Chang JC; Siu LK Microb Drug Resist; 2005; 11(1):31-9. PubMed ID: 15770092 [TBL] [Abstract][Full Text] [Related]
20. Very high prevalence of extended-spectrum beta-lactamase-producing Enterobacteriaceae in bacteriemic patients hospitalized in teaching hospitals in Bamako, Mali. Sangare SA; Rondinaud E; Maataoui N; Maiga AI; Guindo I; Maiga A; Camara N; Dicko OA; Dao S; Diallo S; Bougoudogo F; Andremont A; Maiga II; Armand-Lefevre L PLoS One; 2017; 12(2):e0172652. PubMed ID: 28245252 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]